Jacobio Pharmaceuticals Group Co., Ltd.

SEHK:1167 Lagerbericht

Marktkapitalisierung: HK$1.4b

Jacobio Pharmaceuticals Group Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

n/a

Dividendenausschüttung

n/a

Ausschüttungsquote

Durchschnittlicher Branchenertrag1.1%
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Gewinn pro Aktie-HK$0.45
Erwartete Dividendenrendite in 3 Jahren0%

Aktuelle Dividendenentwicklung

Keine Aktualisierungen

Recent updates

Most Shareholders Will Probably Agree With Jacobio Pharmaceuticals Group Co., Ltd.'s (HKG:1167) CEO Compensation

May 31
Most Shareholders Will Probably Agree With Jacobio Pharmaceuticals Group Co., Ltd.'s (HKG:1167) CEO Compensation

Is Jacobio Pharmaceuticals Group (HKG:1167) Using Debt Sensibly?

May 29
Is Jacobio Pharmaceuticals Group (HKG:1167) Using Debt Sensibly?

We're Hopeful That Jacobio Pharmaceuticals Group (HKG:1167) Will Use Its Cash Wisely

May 10
We're Hopeful That Jacobio Pharmaceuticals Group (HKG:1167) Will Use Its Cash Wisely

Time To Worry? Analysts Are Downgrading Their Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Outlook

Aug 26
Time To Worry? Analysts Are Downgrading Their Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Outlook

We're Not Very Worried About Jacobio Pharmaceuticals Group's (HKG:1167) Cash Burn Rate

Jul 29
We're Not Very Worried About Jacobio Pharmaceuticals Group's (HKG:1167) Cash Burn Rate

We Think Jacobio Pharmaceuticals Group (HKG:1167) Can Afford To Drive Business Growth

Apr 29
We Think Jacobio Pharmaceuticals Group (HKG:1167) Can Afford To Drive Business Growth

What Percentage Of Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Shares Do Insiders Own?

Mar 21
What Percentage Of Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Shares Do Insiders Own?

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab


Dividendenrendite im Vergleich zum Markt

Jacobio Pharmaceuticals Group Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von 1167 im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (1167)n/a
Untere 25 % des Marktes (HK)3.2%
Markt Top 25 % (HK)7.7%
Branchendurchschnitt (Biotechs)1.1%
Analystenprognose in 3 Jahren (1167)0%


Gewinnausschüttung an die Aktionäre


Barausschüttung an die Aktionäre


Entdecken Sie dividendenstarke Unternehmen